Meeting
2024 ASCO Annual Meeting
Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.
Authors
Murtaza Ahmed
Cedars-Sinai Medical Center, Los Angeles, CA
Murtaza Ahmed , Marco Ventin , Giulia Cattaneo , Arya Shahrzad , Anser Ali Abbas , Brent K Larson , John Davelaar , Simon K. Lo , Matthew Ebia , Ashley Wachsman , Srinivas Gaddam , Jun Gong , Nicholas Nissen , Kambiz Kosari , Alexandra Gangi , Andrew Eugene Hendifar , Cristina R. Ferrone , Arsen Osipov
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer - Local-Regional Disease
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 4164)
DOI
10.1200/JCO.2024.42.16_suppl.4164
Abstract #
4164
Poster Bd #
144
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian